PEAK6 Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

PEAK6 Investments’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$5.73K	Buy	+27	New	+$6.91K	﹤0.01%	3266
2024 Q2	–	Sell	-1,874	Closed	-$446K	–	4051
2024 Q1	$501K	Buy	1,874 +1,174	+168%	+$277K	﹤0.01%	2446
2023 Q4	$162K	Sell	700 -1,300	-65%	-$227K	﹤0.01%	3356
2023 Q3	$292K	Sell	2,000 -187	-9%	-$35.2K	﹤0.01%	2799
2023 Q2	$505K	Buy	+2,187	New	+$592K	﹤0.01%	2208
2022 Q3	–	Sell	-2,187	Closed	-$505K	–	5328
2022 Q2	$505K	Buy	+2,187	New	+$161K	﹤0.01%	2209
2020 Q4	–	Sell	-3,466	Closed	-$412K	–	4912
2020 Q3	$412K	Buy	+3,466	New	+$376K	﹤0.01%	3001
2018 Q4	–	Sell	-645	Closed	-$138K	–	4390
2018 Q3	$138K	Buy	+645	New	+$162K	﹤0.01%	3405

Other funds holding MDGL

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PEAK6 Investments's MDGL Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2024: 27 shares worth $5.73K. The stake represents ﹤0.01% of the portfolio and ranks #3266 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in MDGL as recently as Q1 2024.

PEAK6 Investments first reported a position in MDGL in Q3 2018 and has held it in 8 quarters since. The position peaked at $505K in Q2 2023. 257 funds tracked by Wall St. Rank hold MDGL as of Q3 2024.

PEAK6 Investments held 27 shares of Madrigal Pharmaceuticals worth $5.73K as of Q3 2024.
Madrigal Pharmaceuticals was a new PEAK6 Investments position in Q3 2024.
Madrigal Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3266 holding.
PEAK6 Investments first reported a position in Madrigal Pharmaceuticals in Q3 2018 and has held it in 8 quarters since.
PEAK6 Investments's Madrigal Pharmaceuticals position peaked at $505K in Q2 2023.
257 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.